Wedbush Securities’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-45,515
| Closed | -$105K | – | 1051 |
|
|
2020
Q2 | $105K | Buy |
+45,515
| New | +$105K | 0.01% | 855 |
|
|
2020
Q1 | – | Sell |
-19,100
| Closed | -$40K | – | 1052 |
|
|
2019
Q4 | $40K | Buy |
+19,100
| New | +$40K | ﹤0.01% | 971 |
|
|
2019
Q3 | – | Sell |
-11,000
| Closed | -$43K | – | 1056 |
|
|
2019
Q2 | $43K | Buy |
+11,000
| New | +$43K | ﹤0.01% | 954 |
|
|
2018
Q4 | – | Sell |
-1,625
| Closed | -$10K | – | 958 |
|
|
2018
Q3 | $10K | Buy |
+1,625
| New | +$10K | ﹤0.01% | 894 |
|
|
2017
Q4 | – | Sell |
-2,563
| Closed | -$30K | – | 924 |
|
|
2017
Q3 | $30K | Buy |
+2,563
| New | +$30K | ﹤0.01% | 817 |
|
|
2016
Q4 | – | Sell |
-1,429
| Closed | -$59K | – | 906 |
|
|
2016
Q3 | $59K | Buy |
1,429
+63
| +5% | +$2.6K | 0.01% | 783 |
|
|
2016
Q2 | $45K | Buy |
+1,366
| New | +$45K | 0.01% | 736 |
|